Install
Discover BioBuzz — the premier life sciences network delivering news, events, jobs, and opportunities across regional biohealth ecosystems.
- 21articles · 30d
- 3+ day agolatest article
- Aug 20, 2026earliest in window
- 95%with images
- 214avg words
- Business & Industrial 12
- Medical 10
- Health & Wellness 7
- Economy, Business & Finance 6
- Science & Technology 6
- Health 5
- Science & Nature 5
- Finance & Business 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Five of Maryland's 15 RealLIST Innovators for 2026 Have Ties to Life Sciences and Healthcare
3+ day, 16+ hour ago (22+ words) BioBuzz Help us improve your BioBuzz experience....
People on the Move: Latus Bio Names Donald Hayden Chairman and Michael MacLean to Board of Directors
4+ day, 3+ hour ago (97+ words) BioBuzz Hayden holds an M.B.A. from Indiana University and a B.A. from Harvard University. MacLean brings decades of financial leadership across the biotechnology industry to the role, with deep experience funding biotechnology companies advancing novel therapies in the rare and orphan disease…...
PDA and FDA Bring Regulators and Industry Together for 37th Annual Regulatory Conference in D.C.
4+ day, 20+ hour ago (196+ words) According to PDA, the 2026 program brings together more than 75 FDA and industry experts from over 30 companies across more than 20 panel discussions and Q&A sessions, with CDER, CBER, CVM, and the Office of Inspections and Investigations represented throughout. The program…...
UroGen Invests Up to $7 Million in IntraGel to Expand Beyond Urothelial Cancer
2+ week, 4+ day ago (571+ words) BioBuzz UroGen Invests Up to $7 Million in IntraGel to Expand Beyond Urothelial Cancer UroGen Pharma announced strategic collaboration and investment agreements with IntraGel Therapeutics, Ltd., a Nazareth, Israel-based biotech, giving UroGen access to IntraGel’s biodegradable, sustained-release SRGel platform and an…...